sulfamethoxazolehttp://www.unboundmedicine.com/medline/ebm/research/sulfamethoxazoleUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Case Report of Pediatric Gastroenteritis Due to CTX-M-15 Extended-Spectrum beta-Lactamase-Producing Salmonella enterica Serotype Enteritidis.http://www.unboundmedicine.com/medline/ebm/record/19893356/full_citation/Case_Report_of_Pediatric_Gastroenteritis_Due_to_CTX_M_15_Extended_Spectrum_beta_Lactamase_Producing_Salmonella_enterica_Serotype_Enteritidis_Lee KH, Song W, Jeong SH, et al. 
Case Report of Pediatric Gastroenteritis Due to CTX-M-15 Extended-Spectrum beta-Lactamase-Producing Salmonella enterica Serotype Enteritidis. [Journal Article]
Korean J Lab Med 2009 Oct; 29(5):461-4.
Abstract | Full Citation | Find Related Articles In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.http://www.unboundmedicine.com/medline/ebm/record/19889520/full_citation/In_vitro_susceptibility_of_Achromobacter_spp__isolates:_comparison_of_disk_diffusion_Etest_and_agar_dilution_methods_Almuzara M, Limansky A, Ballerini V, et al. 
In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Nov 2.
Abstract | Full Citation | Find Related Articles Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (madrid, spain) and a potential risk characterization.http://www.unboundmedicine.com/medline/ebm/record/19889447/full_citation/Occurrence_of_pharmaceutically_active_compounds_in_surface_waters_of_the_henares_jarama_tajo_river_system__madrid_spain__and_a_potential_risk_characterization_Fernández C, González-Doncel M, Pro J, et al. 
Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (madrid, spain) and a potential risk characterization. [JOURNAL ARTICLE]
Sci Total Environ 2009 Nov 2.
Abstract | Full CitationSusceptibility to Antibiotics of Vibrio sp. AO1 Growing in Pure Culture or in Association with its Hydroid Host Aglaophenia octodonta (Cnidaria, Hydrozoa).http://www.unboundmedicine.com/medline/ebm/record/19888625/full_citation/Susceptibility_to_Antibiotics_of_Vibrio_sp__AO1_Growing_in_Pure_Culture_or_in_Association_with_its_Hydroid_Host_Aglaophenia_octodonta__Cnidaria_Hydrozoa__Stabili L, Gravili C, Boero F, et al. 
Susceptibility to Antibiotics of Vibrio sp. AO1 Growing in Pure Culture or in Association with its Hydroid Host Aglaophenia octodonta (Cnidaria, Hydrozoa). [JOURNAL ARTICLE]
Microb Ecol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?http://www.unboundmedicine.com/medline/ebm/record/19886977/full_citation/Value_of_anti_infective_chemoprophylaxis_in_primary_systemic_vasculitis:_what_is_the_evidenceMoosig F, Holle JU, Gross WL 
Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? [JOURNAL ARTICLE]
Arthritis Res Ther 2009 Oct 28; 11(5):253.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases.http://www.unboundmedicine.com/medline/ebm/record/19884786/full_citation/Antimicrobials_effective_for_inhibition_of_enterohaemorrhagic_Escherichia_coli_strains_O26_O111_and_O157_and_their_effects_on_Shiga_toxin_releases_Lee JH, Stein B 
Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases. [JOURNAL ARTICLE]
J Microbiol Biotechnol 2009 Oct; 19(10):1238-1243.
Abstract | Full Citation | Find Related Articles Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.http://www.unboundmedicine.com/medline/ebm/record/19883154/full_citation/Oral_atovaquone_for_the_treatment_of_severe_Pneumocystis_jirovecii_pneumonia_in_a_patient_with_glucose_6_phosphate_dehydrogenase_deficiency_Douzinas EE, Flevari K, Andrianakis I, et al. 
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. [JOURNAL ARTICLE]
Scand J Infect Dis 2009 Nov 2.
Abstract | Full CitationPhotodegradation of sulfamethoxazole in various aqueous media: Persistence, toxicity and photoproducts assessment.http://www.unboundmedicine.com/medline/ebm/record/19879626/full_citation/Photodegradation_of_sulfamethoxazole_in_various_aqueous_media:_Persistence_toxicity_and_photoproducts_assessment_Trovó AG, Nogueira RF, Agüera A, et al. 
Photodegradation of sulfamethoxazole in various aqueous media: Persistence, toxicity and photoproducts assessment. [JOURNAL ARTICLE]
Chemosphere 2009 Oct 29.
Abstract | Full Citation | Publisher Full TextPneumocystis pneumonia in children.http://www.unboundmedicine.com/medline/ebm/record/19879509/full_citation/Pneumocystis_pneumonia_in_children_Pyrgos V, Shoham S, Roilides E, et al. 
Pneumocystis pneumonia in children. [Journal Article]
Paediatr Respir Rev 2009 Dec; 10(4):192-8.
Abstract | Full CitationEfficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease.http://www.unboundmedicine.com/medline/ebm/record/19879276/full_citation/Efficacy_of_Ceftriaxone_or_Meropenem_as_Initial_Therapies_in_Whipple's_Disease_Feurle GE, Junga NS, Marth T 
Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease. [JOURNAL ARTICLE]
Gastroenterology 2009 Oct 28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles